Literature DB >> 9828108

Correlation of Pit-1 gene expression and Pit-1 content with proliferation and differentiation in human myeloid leukemic cells.

J A Costoya1, M García-Barros, R Gallego, R Señarís, V M Arce, J Devesa.   

Abstract

The transcription factor pituitary-1 (Pit-1) is a homeodomain-containing protein that is expressed mainly in the pituitary, where it drives the expression of growth hormone, prolactin, and thyroid-stimulating hormone beta chain genes. In addition, Pit-1 is required for adequate pituitary cell growth and may be involved in the pathogenesis of pituitary adenomas. Pit-1 expression has been also reported in nonpituitary tissues, where it might be involved in the control of cell proliferation. In order to elucidate such a possibility, we have investigated the changes in both Pit-1 mRNA and Pit-1 immunoreactivity in HL-60 cells following the addition of several differentiating agents. Our results show that while high Pit-1 levels are found in exponentially growing HL-60 cells, a significant decrease occurs after induction of cells to differentiate along the macrophage lineage with 12-O-tetradecanoylphorbol-13-acetate (TPA). In contrast no changes were observed when cells were treated with interferon-alpha, which also induces differentiation of HL-60 cells that, at odds with TPA, is not accompanied with growth arrest. In all, these findings suggest that Pit-1 expression is specifically associated with proliferation in HL-60 cells, thus supporting the idea that one of the functions of nonpituitary Pit-1 may be the control of cell proliferation. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9828108     DOI: 10.1006/excr.1998.4232

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  4 in total

1.  Deregulation of the Pit-1 transcription factor in human breast cancer cells promotes tumor growth and metastasis.

Authors:  Isabel Ben-Batalla; Samuel Seoane; Tomas Garcia-Caballero; Rosalia Gallego; Manuel Macia; Luis O Gonzalez; Francisco Vizoso; Roman Perez-Fernandez
Journal:  J Clin Invest       Date:  2010-11-08       Impact factor: 14.808

2.  Over-Expression of POU Class 1 Homeobox 1 Transcription Factor (Pit-1) Predicts Poor Prognosis for Breast Cancer Patients.

Authors:  Zhongcheng Gao; Kecheng Xue; Lianfang Zhang; Meng Wei
Journal:  Med Sci Monit       Date:  2016-10-31

3.  A novel thymoma-associated autoimmune disease: Anti-PIT-1 antibody syndrome.

Authors:  Hironori Bando; Genzo Iguchi; Yasuhiko Okimura; Yukiko Odake; Kenichi Yoshida; Ryusaku Matsumoto; Kentaro Suda; Hitoshi Nishizawa; Hidenori Fukuoka; Atsuko Mokubo; Katsuyoshi Tojo; Yoshimasa Maniwa; Wataru Ogawa; Yutaka Takahashi
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

4.  POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15).

Authors:  Susana Lisboa; Nuno Cerveira; Susana Bizarro; Cecília Correia; Joana Vieira; Lurdes Torres; José M Mariz; Manuel R Teixeira
Journal:  Mol Cancer       Date:  2013-01-18       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.